An Innovative Cardiac Ablation System for treating cardiac arrhythmias
Developing the next generation of Pulsed Field Ablation and Irreversible Electroporation
Venture-capital backed company
The challenge
RF and Cryo energies are the most commonly used technologies for cardiac ablation for the treatment of atrial fibrillation, Atrial-Flutter and all other Arrhythmia's.
Despite the development of these technologies and increased market adoption, long term success remains in the range of 50-70% depending on patient population.
- These approaches are also associated with adverse events from the use of thermal energies.
- The utilisation of thermal energy, destroys tissue indiscriminately increasing the risk of collateral injuries, such as oesophageal fistulas, pulmonary vein stenosis and phrenic nerve palsy.
- The use of thermal energy may also increase the difficulty to ensure the correct dose of therapy is delivered.
Argá's solution
Argá Medtech is developing the next generation non-thermal cardiac ablation system. Its unique power generator offers unmatched flexibility when used with its proprietary catheter.
There's much more to success in cardiac ablation than to have just a better catheter design or a better energy delivery generator.
Improving cardiac ablation outcomes requires both.
